Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Śląski W KatowicachfiledCriticalUniwersytet Śląski W Katowicach
Priority to PL419320ApriorityCriticalpatent/PL236313B1/en
Publication of PL419320A1publicationCriticalpatent/PL419320A1/en
Publication of PL236313B1publicationCriticalpatent/PL236313B1/en
Investigating Or Analysing Biological Materials
(AREA)
Plural Heterocyclic Compounds
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Przedmiotem zgłoszenia jest nowa pochodna para-iminostyrylochinoliny, która charakteryzuje się tym, że ma strukturę chemiczną według wzoru. Przedmiotem zgłoszenia jest także zastosowanie nowej pochodnej para-iminostyrylochinoliny o wzorze 1 jako barwnika fluorescencyjnego do barwienia struktur biologicznych oraz do wykrywania jonów metali w szczególności jonów cynku w strukturach biologicznych korzystnie w komórkach ludzkich lub zwierzęcych.The subject of the application is a new para-iminostyrylquinoline derivative, which is characterized by having a chemical structure according to the formula. The subject of the application is also the use of a new para-iminostyrylquinoline derivative of the formula I as a fluorescent dye for staining biological structures and for detecting metal ions, in particular zinc ions in biological structures, preferably in human or animal cells.
PL419320A2016-10-312016-10-31New derivative of para-iminostyrylquinoline and its application
PL236313B1
(en)
Macrocyclic compounds, membrane specific prostate antigen (psma) inhibitors; pharmaceutical composition; metal complex; and its use to prepare radiolabelled compounds useful for imaging to diagnose and for the treatment of prostate cancer and / or metastasis thereof.
FORMS OF SALT OF 4-CIANO-N- (2- (4,4-DIMETILCICLOHEX-1-EN-1-IL) -6- (2,2,6,6-TETRAMETILTETRAHIDRO-2H-PIRAN-4-IL) PIRIDIN-3-IL) -1HIMIDAZOL-2-CARBOXAMIDE AND COMPOSITIONS CONTAINING THEM